BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Ovarian Cancer
NCI Information
Our Treatment Approach
Clinical Trials
Support Groups
Effects of Treatment
Assess Your Risk
Podcasts
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
GOG 0255
Principal Investigator:
Mutch, David
Title:
A Phase II Randomized Double-Blind Trial Of A Polyvalent Vaccine-KLH Conjugate (NSC 748933 IND# 14384) + OPT-821 Versus OPT-821 In Patients With Epithelial Ovarian, Fallopian Tube, Or Peritoneal Cancer Who Are In Second Or Third Complete Remission
Phase:
II
Disease Site:
Multiple Sites
Participating Site(s):
Main Campus
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The purpose of this research is to study a vaccine treatment for patients with ovarian, fallopian tube, or peritoneal cancer, and see if the vaccine may be able to delay or prevent your cancer from returning again.
More Information:
(Links will take you off this web site)
Internal Protocol Documents (requires Siteman administrative database password)